Financhill
Back

Ascendis Pharma AS Quote, Financials, Valuation and Earnings

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
43

ASND
Ascendis Pharma AS

Last Price:
$136.20
Seasonality Move:
19.34%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Ascendis Pharma AS Price Quote

$136.20
-0.04 (-1.12%)
(Updated: December 21, 2024 at 5:15 AM ET)

Ascendis Pharma AS Key Stats

Sell
43
Ascendis Pharma AS (ASND) is a Sell

Day range:
$135.61 - $141.37
52-week range:
$111.09 - $161.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.92
P/B ratio:
0%

Volume:
632.7K
Avg. volume:
509.4K
1-year change:
12.45%
Market cap:
$8.1B
Revenue:
$288.8M
EPS:
$-8.11

How Much Does Ascendis Pharma AS Make?

Data Unavailable

Is Ascendis Pharma AS Growing As A Company?

Data Unavailable

Ascendis Pharma AS Stock Price Performance

What Is Ascendis Pharma AS 52-Week High & Low?

Ascendis Pharma AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ascendis Pharma AS?

Data Unavailable

Is Ascendis Pharma AS Cash Flow Positive?

Data Unavailable

Ascendis Pharma AS Return On Invested Capital

Data Unavailable

Ascendis Pharma AS Earnings Date & Stock Price

Ascendis Pharma AS Competitors

  • Who Are Ascendis Pharma AS's Competitors?
    Below is a list of companies who compete with Ascendis Pharma AS or are related in some way:
    • Akari Therapeutics PLC (AKTX)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • Evaxion Biotech AS (EVAX)
    • Novo Nordisk AS (NVO)
    • Trinity Biotech PLC (TRIB)

Ascendis Pharma AS Dividend Yield

Data Unavailable

Ascendis Pharma AS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -15.93%
Revenue: 21.62% -17.39%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 189.82
Upside from Last Price: 39.33%

Major Shareholders

Data Unavailable